德国降脂疗法的治疗途径 2016-2022年
Julius L Katzmann1, Claudia Grellmann2, Beate Leppert3
1Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Germany. julius.katzmann@medizin.uni-leipzig.de.
概括
德国大多数患有高心血管风险的患者,尽管有可用的降脂疗法 (LLT),但无法达到LDL胆固醇目标. 治疗变化很少发生,他类药物主导了最初的处方,较新的药物,如bempedoic acid (BA) 和PCSK9抑制剂 (PCSK9i) 较少使用.
科学领域:
- 心血管医学 心血管医学
- 药物治疗 药物治疗
- 医疗保健服务研究 医疗服务研究
背景情况:
- 有效的降低LDL胆固醇 (LDL-C) 的药物可供使用,但少数患者达到指南推的治疗目标.
- 了解降脂疗法 (LLT) 的治疗途径对于改善德国心血管风险管理至关重要.
研究的目的:
- 分析德国高或非常高心血管风险患者的降脂疗法 (LLT) 治疗途径.
- 评估不同类型的LLT的利用模式,切换和停止率.
主要方法:
- 德国2016-2022年健康声明数据的分析.
- 包括接受LLT的高/非常高心血管风险患者.
- 检查治疗途径,切换时间和停止治疗他类药物,ezetimibe,bempedoic acid (BA) 和PCSK9抑制剂 (PCSK9i).
主要成果:
- 类药物是主要的第一线LLT (96.3%),以西西米布,BA和PCSK9i不经常使用 (<1%).
- 在LLT开始后,治疗方案的改变并不常见.
- 与他类药物和ezetimibe相比,BA和PCSK9i主要被用作附加疗法;与他类药物和ezetimibe相比,BA的停止时间较早 (0.60年),而PCSK9i的停止时间较晚 (2.45年).
结论:
- 在德国,在高风险患者中,LLT的治疗修改是罕见的.
- 与他类药物和ezetimibe相比,佩多酸 (BA) 和PCSK9抑制剂 (PCSK9i) 显示出不同的停止模式.
- 需要持续努力来增强长期坚持和克服治疗惯性,以最大限度地发挥现有的LLT的好处.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Vapor Pressure Lowering
30.7K
The equilibrium vapor pressure of a liquid is the pressure exerted by its gaseous phase when vaporization and condensation are occurring at equal rates:
30.7K
What are Lipids?
219.2K
Overview
219.2K
Lipid Digestion
98.9K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.9K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
596
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
596
Structure of Lipids
98.4K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
98.4K


